CVS and the Opioid Crisis: A Financial Fallout

This chapter explores the decline of CVS following leadership changes and its legal struggles related to the opioid crisis, highlighting how aggressive pricing strategies and poor financial decisions led to executive oustings. It details the significant impact of a recent lawsuit by the Justice Department, linking CVS's practices to increased opioid prescriptions and subsequent stock decline. The chapter also examines broader investment strategies and stock evaluations as listeners seek insights into managing their portfolios amidst challenging market conditions.